Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals Limited is preparing to launch its Initial Public Offering (IPO) to raise funds for expanding its pharmaceutical business. The company primarily focuses on manufacturing and marketing a wide range of pharmaceutical products, including tablets, capsules, ointments, and liquid formulations. It caters to both the domestic and international markets, offering contract manufacturing services to over 200 clients.